Financials
Financial year 2026
NADIMED from Kontich, company number BE0859727529, closed financial year 2026 with a result of € 112,140 after tax. For that financial year NADIMED recorded revenue of € 13 million and equity of € 821,966. Compared with financial year 2025, the result moved from € 607,597 to € 112,140. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 15, 2026.
€ 821,966
▼ 33% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 112,140
▼ 82% vs 2025
Profit after tax over the fiscal year.
€ 814,957
▼ 51% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 500,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2026
4.3
▲ 1.2 vs 2025
Average over the fiscal year, from the social balance sheet.
€ 456,917
▲ 92% vs 2025
€ 106,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,909
▼ 45% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 814,978
▲ 16% vs 2025
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 24 days on average.
€ 63,956
▲ 82% vs 2025
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Revenue | - | € 15,113,196 | € 12,190,131 | € 13,048,153 | ▲ 7% |
| Gross margin | € 2,075,323 | - | - | - | |
| Profit after taxes | € 1,372,734 | € 808,334 | € 607,597 | € 112,140 | ▼ 82% |
| Equity | € 5,179,428 | € 5,172,917 | € 1,224,301 | € 821,966 | ▼ 33% |
| Total debts | € 800,352 | € 1,761,318 | € 1,925,413 | € 1,450,484 | ▼ 25% |
| Cash | € 3,609,374 | € 1,518,470 | € 1,673,067 | € 814,957 | ▼ 51% |
| Retained profit | € 5,160,828 | € 5,154,317 | € 1,205,701 | € 803,366 | ▼ 33% |
| Dividend | € 0 | € 808,334 | € 4,550,000 | € 500,000 | ▼ 89% |
| Balance sheet total | € 5,979,780 | € 6,934,235 | € 3,149,714 | € 2,272,450 | ▼ 28% |
| Employees (FTE) | 2.4 | 2.7 | 3.1 | 4.3 | ▲ 1.2 |
Key figures of NADIMED, fiscal years 2022 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to NADIMED?
What happened at NADIMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 112,140 (▼ 82% vs 2025). Source: NBB ↗
- William Sanders became a director. NBB
- New establishment in Kontich. KBO
- Start of the company according to the CBE. KBO
In short
From € 1.4 million profit in 2022 to € 112,140 profit in 2026.
Paid € 919,390 in corporate taxes since 2022.
Best year ever: 2022, with € 1.4 million profit.
On average € 864,700 of value added per employee in 2022.
A new publication or filing at NADIMED? We notify you, reason included.
Follow NADIMEDDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind NADIMED is William Sanders. The shares are held by Mawdsley-Brooks Europe BV (100%).
Directors
According to the 2026 annual accounts
since 2023
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Prins Boudewijnlaan 7b box 18
2550 Kontich
Prins Boudewijnlaan 7B box 18
2550 Kontich
Active since 1 June 2020
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0859.727.529
- VAT number
- BE 0859.727.529
- Registered office
- Prins Boudewijnlaan 7b bus 18, 2550 Kontich
- Names & denominations
- NADIMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 July 2003
- Peppol
- Active · Active since 9 May 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten